| |
| |
|
| Insider
Information: |
Pakianathan Deepika |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
66,879 |
|
|
Indirect Shares
|
2,855,205 |
|
|
| Direct
Value |
$630,336 |
|
|
|
Indirect Value
|
$53,609,158 |
|
|
| Total
Shares |
2,922,084 |
|
|
| Total
Value |
$54,239,494 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -231.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2016-06-21 |
0 |
2016-06-21 |
0 |
Premium* |
|
|
Karyopharm Therapeutics Inc. |
KPTI |
Director |
2013-11-12 |
0 |
2022-06-10 |
16,673 |
Premium* |
|
|
Trivascular Technologies, Inc. |
TRIV |
10% Owner |
2014-04-22 |
0 |
2016-02-03 |
0 |
Premium* |
|
|
Alder Biopharmaceuticals Inc |
ALDR |
Director, 10% Owner |
2014-05-13 |
0 |
2014-05-13 |
2,838,532 |
Premium* |
|
|
Calithera Biosciences, Inc. |
CALA |
Director |
2014-10-07 |
0 |
2023-01-27 |
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2023-05-02 |
36,879 |
2020-07-01 |
0 |
Premium* |
|
|
Pardes Biosciences Ord Shs |
PRDS |
Director |
2021-12-23 |
30,000 |
2021-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
|
– • – |
2023-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,132 |
36,879 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
Director |
– • – |
2023-01-27 |
4 |
S |
$0.39 |
$46,810 |
I/I |
(121,333) |
0 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
Director |
– • – |
2022-06-10 |
4 |
S |
$6.00 |
$7,844 |
I/I |
(1,307) |
16,673 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
Director |
– • – |
2022-06-09 |
4 |
S |
$6.18 |
$1,307,028 |
I/I |
(211,500) |
16,686 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
Director |
– • – |
2022-06-08 |
4 |
S |
$6.50 |
$2,119,926 |
I/I |
(325,977) |
18,731 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
|
– • – |
2022-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,852 |
27,747 |
0 |
- |
|
| PRDS |
Pardes Biosciences Ord Sh... |
Director |
– • – |
2021-12-23 |
4/A |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| PRDS |
Pardes Biosciences Ord Sh... |
Director |
– • – |
2021-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
52,500 |
52,500 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2021-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,828 |
17,895 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,067 |
8,067 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2016-06-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(98,967) |
0 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Director |
– • – |
2016-06-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(658) |
0 |
0 |
- |
|
| TRIV |
Trivascular Technologies,... |
10% Owner |
– – • |
2016-02-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,535,910) |
0 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Director |
– • – |
2015-01-12 |
4 |
B |
$33.00 |
$1,499,982 |
I/I |
45,454 |
21,883 |
2.1 |
- |
|
| CALA |
Calithera Biosciences, In... |
Director |
– • • |
2014-10-07 |
4 |
B |
$10.00 |
$5,000,000 |
I/I |
500,000 |
23,464 |
2.25 |
- |
|
| CALA |
Calithera Biosciences, In... |
Director |
– • • |
2014-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,926,702 |
18,629 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Director |
– • – |
2014-05-23 |
4 |
B |
$26.45 |
$46,784 |
I/I |
1,769 |
21,443 |
2.1 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Director |
– • – |
2014-05-22 |
4 |
B |
$26.09 |
$521,804 |
I/I |
20,000 |
21,426 |
2.1 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Director |
– • – |
2014-05-21 |
4 |
B |
$26.19 |
$2,426,874 |
I/I |
92,650 |
21,233 |
2.1 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Director |
– • • |
2014-05-13 |
4 |
B |
$10.00 |
$3,500,000 |
I/I |
350,000 |
2,838,532 |
2.25 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Director |
– • • |
2014-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,488,532 |
2,488,532 |
0 |
- |
|
| TRIV |
Trivascular Technologies,... |
10% Owner |
– – • |
2014-04-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,702,577 |
3,535,910 |
0 |
- |
|
| TRIV |
Trivascular Technologies,... |
10% Owner |
– – • |
2014-04-22 |
4 |
B |
$12.00 |
$9,999,996 |
I/I |
833,333 |
833,333 |
1.5 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Director |
– • – |
2013-11-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,790,633 |
17,315 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Director |
– • – |
2013-11-12 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
20,337 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
